Kaya Holdings (KAYS) Gross Margin (2014 - 2025)
Kaya Holdings (KAYS) recorded quarterly Gross Margin of 99.3% in Q3 2025, up 198.22% quarter-over-quarter from 33.3% in Q2 2025, and up 836.0% on a YoY basis from 10.61% in Q3 2024.
Kaya Holdings (KAYS) Gross Margin (2014 - 2025) Analysis & Trends
Kaya Holdings' Gross Margin history runs 12 years deep, the most recent figure standing at 99.3% for Q3 2025.
- In Q3 2025, Gross Margin rose 836.0% year-over-year to 99.3%; the TTM figure through Sep 2025 stood at 522.23% (up 47863.0% YoY), while the FY2024 annual figure was 5.13%, down 6369.0% from the prior year.
- Gross Margin was 99.3% for Q3 2025 at Kaya Holdings, up from 33.3% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 99.3% in Q3 2025 to a low of 29.52% in Q1 2025.
- Historically, Gross Margin has averaged 63.76% across 5 years, with a median of 65.86% in 2023.
- The sharpest annual moves came in 2023 and 2024: Gross Margin sank 3439 bps in 2023, then soared 4176 bps in 2024.
- A 5-year view of Gross Margin shows it stood at 72.68% in 2021, then dropped by 8 bps to 66.76% in 2022, then sank by 52 bps to 32.37% in 2023, then jumped by 129 bps to 74.12% in 2024, then surged by 34 bps to 99.3% in 2025.
- The last three Gross Margin figures came in at 99.3% (Q3 2025), 33.3% (Q2 2025), and 29.52% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -293.83% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 61.20% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 65.25% |
| 10 | Kaya Holdings | - | - | 5,370.00 | 99.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 99.30% |
| Jun 30, 2025 | 33.30% |
| Mar 31, 2025 | 29.52% |
| Dec 31, 2024 | 74.12% |
| Sep 30, 2024 | 90.93% |
| Mar 31, 2024 | 52.14% |
| Dec 31, 2023 | 32.37% |
| Sep 30, 2023 | 62.57% |
| Jun 30, 2023 | 64.23% |
| Mar 31, 2023 | 65.60% |
| Dec 31, 2022 | 66.76% |
| Sep 30, 2022 | 65.44% |
| Jun 30, 2022 | 69.93% |
| Mar 31, 2022 | 66.13% |
| Dec 31, 2021 | 72.68% |
| Sep 30, 2021 | 70.92% |
| Jun 30, 2021 | 63.74% |
| Mar 31, 2021 | 68.01% |
| Dec 31, 2020 | 62.40% |
| Sep 30, 2020 | 61.50% |